Listening for Disease using Artificial Intelligence
An intelligent, AI-enabled stethoscope for accurate early detection of heart and lung disease
Re-inventing the stethoscope
The stethoscope was invented over 200 years ago and hasn’t changed significantly since.
At biophonics®, we are combining novel hardware and and state of the art machine learning techniques to develop the next generation of stethoscopes.
We are a spinout from the University of Cambridge Acoustics Lab.
HEART DISEASE IS A GROWING PROBLEM
1.5 million people in the UK suffer from significant heart valve disease
This figure is expected to double by 2050 as the population ages.
More than half of these cases (0.8 million) are undiagnosed.
Early detection of the disease is essential, but clinicians can struggle to hear the disease when using a traditional stethoscope.
Unnecessary referrals put an immense strain on hospital cardiology departments, whereas late diagnoses can severely affect patient prognoses.
Source: J. d’Arcy et al. (2016). Large-scale community echocardiographic screening reveals a major burden of undiagnosed valvular heart disease in older people: the OxVALVE Population Cohort Study. European Heart Journal, 37(47) : 3515-3522.
We are applying machine learning techniques to automatically detect murmurs and diagnose valvular heart disease.
The software will speed up detection of asymptomatic disease, reduce unnecessary referrals and make the stethoscope useful for those with less medical training.
An early version of our software won an award at the Computing in Cardiology Conference 2016 (paper). It has since been improved, achieving a false positive rate of 2% and a false negative rate of 5% (Patent pending).
We are collaborating with clinicians across the UK to gather new data and continually improve our diagnoses.